Junichi Asano

470 total citations
26 papers, 309 citations indexed

About

Junichi Asano is a scholar working on Molecular Biology, Statistics and Probability and Oncology. According to data from OpenAlex, Junichi Asano has authored 26 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Statistics and Probability and 6 papers in Oncology. Recurrent topics in Junichi Asano's work include Statistical Methods in Clinical Trials (6 papers), Cancer Genomics and Diagnostics (4 papers) and Chemical Synthesis and Analysis (3 papers). Junichi Asano is often cited by papers focused on Statistical Methods in Clinical Trials (6 papers), Cancer Genomics and Diagnostics (4 papers) and Chemical Synthesis and Analysis (3 papers). Junichi Asano collaborates with scholars based in Japan, United States and Netherlands. Junichi Asano's co-authors include Akihiro Hirakawa, Satoshi Teramukai, Hiroyuki Sato, Norio Sakai, Takeo Konakahara, Chikuma Hamada, Tadao Orii, Akihiro Hirakawa, Shinichi Noda and Yoshiaki Maruyama and has published in prestigious journals such as Tetrahedron, Clinical Pharmacology & Therapeutics and Medicine.

In The Last Decade

Junichi Asano

25 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Junichi Asano Japan	11	131	62	49	43	41	26	309
Sally Clive United Kingdom	13	178 1.4×	76 1.2×	22 0.4×	62 1.4×	190 4.6×	30	500
Marinus W. Lobbezoo United States	8	85 0.6×	87 1.4×	22 0.4×	94 2.2×	89 2.2×	13	280
Jamie Munro United Kingdom	3	160 1.2×	20 0.3×	17 0.3×	24 0.6×	59 1.4×	4	411
W Schmidt United States	8	92 0.7×	30 0.5×	46 0.9×	67 1.6×	155 3.8×	12	348
Michael W. Bolt United States	9	162 1.2×	14 0.2×	10 0.2×	24 0.6×	42 1.0×	16	419
Cathy Tralau-Stewart United Kingdom	7	183 1.4×	7 0.1×	37 0.8×	36 0.8×	50 1.2×	11	411
Barbara Mounho United States	10	210 1.6×	9 0.1×	13 0.3×	60 1.4×	76 1.9×	12	484
Hille Gieschen Germany	12	90 0.7×	10 0.2×	27 0.6×	72 1.7×	105 2.6×	16	455
Helen Tomkinson United Kingdom	13	144 1.1×	22 0.4×	26 0.5×	18 0.4×	178 4.3×	40	447
Ohad Amit United States	9	147 1.1×	87 1.4×	8 0.2×	57 1.3×	125 3.0×	11	556

Countries citing papers authored by Junichi Asano

Since Specialization

Citations

This map shows the geographic impact of Junichi Asano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junichi Asano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junichi Asano more than expected).

Fields of papers citing papers by Junichi Asano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junichi Asano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junichi Asano. The network helps show where Junichi Asano may publish in the future.

Co-authorship network of co-authors of Junichi Asano

This figure shows the co-authorship network connecting the top 25 collaborators of Junichi Asano. A scholar is included among the top collaborators of Junichi Asano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junichi Asano. Junichi Asano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Noda, Shinichi, et al.. (2025). Regulatory advancements in Japan's conditional and time-limited approval scheme for regenerative medical products: the first guidance on the approval scheme and the second review for full approval of the first conditional and time-limited approved cellular product, HeartSheet. Cytotherapy. 27(6). 700–708. 1 indexed citations

Asano, Junichi, et al.. (2025). PMDA Perspective on Use of Real‐World Data and Real‐World Evidence as an External Control: Recent Examples and Considerations. Clinical Pharmacology & Therapeutics. 117(4). 910–919. 1 indexed citations

Maruyama, Yoshiaki, et al.. (2023). Regulatory Issues: PMDA – Review of Sakigake Designation Products: Oncolytic Virus Therapy with Delytact Injection (Teserpaturev) for Malignant Glioma. The Oncologist. 28(8). 664–670. 17 indexed citations

Aketa, Naohiko, et al.. (2023). Insights into the clinical development of regenerative medical products through a comparison of three cell-based products recently approved for limbal stem cell deficiency. The Ocular Surface. 29. 220–225. 12 indexed citations

Sugihara, Takahiko, Junichi Asano, Midori Sato, et al.. (2022). Clinical characteristics of COVID-19 patients with underlying rheumatic diseases in Japan: data from a multicenter observational study using the COVID-19 Global Rheumatology Alliance physician-reported registry. Clinical Rheumatology. 41(12). 3661–3673. 4 indexed citations

Asano, Junichi, et al.. (2021). Assessment of the impact of Japanese‐specific long‐term safety data on new drug approval. Clinical and Translational Science. 14(6). 2339–2347. 3 indexed citations

Hirakawa, Akihiro, Junichi Asano, Hiroyuki Sato, & Satoshi Teramukai. (2019). Cancer Clinical Trials Based on Master Protocol. 39(2). 85–101. 1 indexed citations

Hirakawa, Akihiro, Junichi Asano, Hiroyuki Sato, & Satoshi Teramukai. (2018). Master protocol trials in oncology: Review and new trial designs. Contemporary Clinical Trials Communications. 12. 1–8. 72 indexed citations

Asano, Junichi & Akihiro Hirakawa. (2017). Assessing the prediction accuracy of a cure model for censored survival data with long-term survivors: Application to breast cancer data. Journal of Biopharmaceutical Statistics. 27(6). 918–932. 7 indexed citations

10.

Ikuma, Mutsuhiro, et al.. (2015). Exposure of Drugs for Hypertension, Diabetes, and Autoimmune Disease During Pregnancy and Perinatal Outcomes. Medicine. 94(1). e386–e386. 10 indexed citations

11.

Asano, Junichi, Akihiro Hirakawa, & Chikuma Hamada. (2014). Assessing the prediction accuracy of cure in the Cox proportional hazards cure model: an application to breast cancer data. Pharmaceutical Statistics. 13(6). 357–363. 20 indexed citations

12.

Asano, Junichi, Akihiro Hirakawa, Chikuma Hamada, et al.. (2013). Use of Cox’s Cure Model to Establish Clinical Determinants of Long-Term Disease-Free Survival in Neoadjuvant-Chemotherapy-Treated Breast Cancer Patients without Pathologic Complete Response. International Journal of Breast Cancer. 2013. 1–9. 8 indexed citations

13.

Sakai, Norio, et al.. (2008). A practical approach to non-natural or N-unsubstituted α-arylglycine derivatives: Hf(OTf)4-doped Me3SiCl system-catalyzed aminomethylation of electron-rich arenes with a new type of N,O-acetal. Tetrahedron. 64(39). 9208–9215. 22 indexed citations

14.

Inagaki, Masumi, et al.. (1995). Reappearance of visual and somatosensory evoked potentials in a patient with childhood adrenoleukodystrophy after bone marrow transplantation and dietary erucic acid therapy. Pediatrics International. 37(1). 125–128. 1 indexed citations

15.

Asano, Junichi, Yasuyuki Suzuki, Kyoko Inoue, et al.. (1994). Effects of erucic acid therapy on Japanese patients with X-linked adrenoleukodystrophy. Brain and Development. 16(6). 454–458. 16 indexed citations

16.

Masuno, Mitsuo, et al.. (1993). Balanced complex rearrangement involving chromosomes 8, 9, and 12 in a normal mother, derivative chromosome 9 with recombinant chromosome 12 in her daughter with minor anomalies. American Journal of Medical Genetics. 45(1). 65–67. 16 indexed citations

17.

Maeda, Keiko, Yasuyuki Suzuki, Junichi Asano, et al.. (1992). Improvement of clinical and MM findings in a boy with adrenoleukodystrophy by dietary erucic acid therapy. Brain and Development. 14(6). 409–412. 7 indexed citations

18.

Asano, Junichi, Shunji Tomatsu, Kazuko Sukegawa, et al.. (1991). Gene deletions in Japanese patients with Duchenne and Becker muscular dystrophies: deletion study and carrier detection. Clinical Genetics. 39(6). 419–424. 9 indexed citations

19.

Nakagawa, Masanori, Keiichi Nakahara, Hiroaki Yoshidome, et al.. (1991). Epidemiology of Progressive Muscular Dystrophy in Okinawa, Japan. Neuroepidemiology. 10(4). 185–191. 29 indexed citations

20.

Asano, Junichi, Shunji Tomatsu, Kazuko Sukegawa, et al.. (1990). Gene deletions in Japanese patients with Duchenne and Becker muscular dystrophy. The Japanese Journal of Human Genetics. 35(2). 159–168. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact